LEADER 01506nam  2200397Ia 450 
001 9910698843803321
005 20120912142041.0
035   $a(CKB)5470000002397428
035   $a(OCoLC)326877876
035   $a(EXLCZ)995470000002397428
100   $a20090519d2006      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $econsiderations for developmental toxicity studies for preventive and therapeutic vaccines for infectious disease indications
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,$d[2006]
215   $ai, 12 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on May 19, 2009).
300   $a"February 2006".
320   $aIncludes bibliographical references (page 12).
517   $aGuidance for industry 
606   $aDevelopmental toxicology$zUnited States
606   $aVaccines$zUnited States$xEvaluation
606   $aCommunicable diseases$xPrevention
615  0$aDevelopmental toxicology
615  0$aVaccines$xEvaluation.
615  0$aCommunicable diseases$xPrevention.
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698843803321
996   $aGuidance for industry$93434577
997   $aUNINA